A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route
Open Access
- 15 June 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (30) , 47287-47301
Abstract
A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous routeKeywords
This publication has 54 references indexed in Scilit:
- Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyondTrends in Molecular Medicine, 2012
- Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivityCell Death & Disease, 2012
- Characterization of Empty Adenovirus Particles Assembled in the Absence of a Functional Adenovirus IVa2 ProteinJournal of Virology, 2011
- Retargeting of Adenovirus Vectors through Genetic Fusion of a Single-Chain or Single-Domain Antibody to Capsid Protein IXJournal of Virology, 2010
- Atomic Structure of Human Adenovirus by Cryo-EM Reveals Interactions Among Protein NetworksScience, 2010
- Improved Antitumor Activity and Tumor Targeting of NH2-Terminal–Specific PEGylated Tumor Necrosis Factor–Related Apoptosis-Inducing LigandMolecular Cancer Therapeutics, 2010
- Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or ImmunizationJournal of Virology, 2010
- In Vitro Dynamic Visualization Analysis of Fluorescently Labeled Minor Capsid Protein IX and Core Protein V by Simultaneous DetectionJournal of Molecular Biology, 2010
- The C-Terminal Domains of Adenovirus Serotype 5 Protein IX Assemble into an Antiparallel Structure on the Facets of the CapsidJournal of Virology, 2009
- Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsidGene Therapy, 2007